| 查看: 391 | 回复: 2 | ||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | ||
[求助]
求助一篇文献,药剂学 脂质体避免抗生素耐药性的
|
||
|
title:Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model. Abstract OBJECTIVES: Methicillin-resistant Staphylococcus aureus (MRSA) poses a major problem to public health worldwide. MRSA strains with increased resistance to vancomycin cause infections that are associated with greater morbidity and threaten the use of this once gold-standard antistaphylococcal drug. We investigated whether encapsulation of vancomycin within liposomes could improve its antistaphylococcal activity. METHODS: Two liposomal formulations of vancomycin were prepared using a rehydration-dehydration method. MICs and MBCs of the liposomal vancomycin for strains of MRSA were determined. The efficacy of one of the liposomal vancomycin formulations was also investigated in a time-kill assay in vitro and in a murine systemic infection model. RESULTS: Encapsulation in either liposome preparation decreased the vancomycin MICs and MBCs for MRSA strains by approximately 2-fold. Liposomal vancomycin increased killing of MRSA in vitro in a kinetic study. In a systemic murine infection model, treatment with a 50 mg/kg intraperitoneal injection of liposomal vancomycin improved kidney clearance of a USA300 strain by 1 log compared with an injection of 50 mg/kg of free vancomycin. CONCLUSIONS: Our findings suggest that entrapment within liposomes could improve the antistaphylococcal efficacy of vancomycin. |
» 猜你喜欢
售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急
已经有7人回复
售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急
已经有6人回复
售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急
已经有7人回复
售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急
已经有8人回复
售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急
已经有6人回复
售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急
已经有6人回复
售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急
已经有7人回复
售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急
已经有5人回复
售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急
已经有5人回复
售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急
已经有5人回复

3楼2012-10-27 21:33:31

2楼2012-10-27 18:54:05










回复此楼